Here’s why I’d invest £1,000 in these two FTSE 100 stocks in a Stocks and Shares ISA today

These two FTSE 100 (INDEXFTSE:UKX) shares could offer impressive long-term returns in my opinion.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The continued fall in the FTSE 100’s price level due to coronavirus fears could cause many investors to adopt a cautious attitude. After all, the stock market could decline further in the near term, which may make less risky assets such as cash and bonds appear to be more attractive.

However, the FTSE 100 contains a number of companies that offer defensive qualities. As such, they could offer superior performances relative to their index peers. Here are two such stocks that could deliver impressive total returns in the long run, as well as relatively low risks in the short term.

AstraZeneca

The AstraZeneca (LSE: AZN) share price has held up relatively well in recent weeks compared to the wider FTSE 100. Investors continue to be buoyed by the company’s improving financial performance over the past couple of years, with the business delivering bottom-line growth following a long period of decline.

Looking ahead, further earnings growth is forecast by the market. AstraZeneca is expected to post a rise in its bottom line of 25% next year, which could catalyse investor sentiment. It may also lead to a rising dividend, which may increase the income appeal of the stock while it has a dividend yield of 2.8% following its recent share price rise.

In addition, the pharmaceutical company’s financial performance may be less negatively impacted by market uncertainty. With investor sentiment having weakened in recent months as the threat of a slowdown in the world economy’s growth rate has increased due to the coronavirus, AstraZeneca’s defensive characteristics may increase its popularity among risk-averse investors.

As such, now could be the right time to buy the stock as it delivers improving financial performance despite a weakening global economic outlook.

Severn Trent

Another FTSE 100 company that appears to offer defensive characteristics is Severn Trent (LSE: SVT). The utility company’s outlook has improved over the past couple of months since the possibility of the sector being nationalised has declined considerably following the general election.

This could make investors more upbeat about the prospects for utility companies – especially since they have a solid track record of dividend growth and their business models are relatively immune to the prospects for the wider economy. Their increasing popularity among investors could catalyse their share prices over the medium term.

Since Severn Trent has a dividend yield of 3.8%, it seems to offer fair value for money. Certainly, there are risks ahead for the sector, such as from regulatory change. But with the UK economy facing an uncertain period due to Brexit, and the world economy’s growth rate having been negatively impacted by the coronavirus, the risk/reward ratio offered by Severn Trent could mean that now is the right time to buy a slice of it and hold it for the long run.

Peter Stephens owns shares of AstraZeneca. The Motley Fool UK has recommended AstraZeneca. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Two white male workmen working on site at an oil rig
Dividend Shares

More oil wobbles as the BP share price dives 7% in a day!

The BP share price has been wildly volatile in 2026, bouncing around with each new move in the US-Iran war.…

Read more »

British bank notes and coins
Investing Articles

Meet the 9.6%-yielding income share that could keep growing its payout!

This income share yields close to 10% -- and has grown its dividend per share year after year for well…

Read more »

Fireworks display in the shape of willow at Newcastle, Co. Down , Northern Ireland at Halloween.
Investing Articles

When will Barclays shares hit £10?

Barclays shares were close to £1 not so long ago, but could they do the unthinkable and make it to…

Read more »

Picture of an easyJet plane taking off.
Investing Articles

easyJet shares have bounced back before. On a P/E ratio of 6, could they do it again?

Our writer thinks easyJet shares could turn out to be a terrific bargain from a long-term perspective. So is he…

Read more »

Stack of British pound coins falling on list of share prices
Investing Articles

Could National Grid shares offer me a dividend that won’t be hurt by inflation?

National Grid aims to inflation-proof its dividend per share with a policy of annual rises that match inflation. Is our…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Here’s what happened to £1,000 invested in the past 2 stock market crashes

History may not repeat itself, but our writer reckons there are lessons to be learned from what recent stock market…

Read more »

Young Caucasian woman at the street withdrawing money at the ATM
Investing Articles

Here’s how the HSBC share price reached an all-time high… and what might be next

HSBC’s record share price reflects a strong rebound in profits and investor confidence, but future gains may be bumpier from…

Read more »

UK coloured flags waving above large crowd on a stadium sport match.
Investing Articles

Investors tempted by beaten-down Diageo shares should mark 6 May on their calendars now

Diageo is a top British blue-chip but its shares have come under fire in recent years. Harvey Jones hopes investors…

Read more »